好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Longitudinal Analysis of Interictal EEGs in Patients with TLE and Hippocampal Sclerosis
Epilepsy/Clinical Neurophysiology (EEG)
P4 - Poster Session 4 (5:30 PM-6:30 PM)
6-007

To investigate the pattern of changes in routine EEGs over time.

Patients with temporal lobe epilepsy (TLE) and hippocampal sclerosis (HS) present a widespread pattern of abnormalities extending beyond the temporal lobe. Although some studies have confirmed progression of structural alterations over time, fewer studies investigated the dynamic changes of interictal epileptiform discharges (IED) during the long-term follow-up.


We evaluated 315 patients, (201 females, with a mean epilepsy duration of 36 years) with 4175 routine EEGs (average of 13.3 EEGs/patient). Six patients presented bilateral HS, 165 left, and 144 right HS (groups balanced for sex, p=0.6). The EEGs were classified as: i) "Ipsilateral IEDs" (n=1661) when there was only IEDs ipsilateral to the HS; ii) "Bilateral+Contraleral IEDs" (n=617), and iii) “Normal EEGs" (n=1897). The duration of epilepsy when the EEG was performed (average=28.9 years) was divided into a) <8y: EEGs performed with less than 8 years from the first seizure; b) 8-17y from the first seizure, c) 18-29y and d) >30y. We performed an analysis of variance adjusted for multiple comparisons to investigate the differences within EEG classes over the different time categories.

 

While the relative numbers of Bilateral+Contraleral IEDs remained stable over time, there was a significant increase of Ipsilateral IEDs (from 22% to 41%, p<0.0001) with a decrease of Normal EEGs (from 69% to 45%; p<0.005). The pairwise comparisons of Ipsilateral IEDs were significant for <8y vs. 18-29y (p=0.005), <8y vs. >30y (p<0.0001), 8-17y vs. >30y (p=0.0002) and 18-29y vs. >30y (p=0.045), and Normal EEGs differed for most of comparisons (p<0.001).

Contrary to expectations, our results did not demonstrate an increase of bilateral IEDs over time. Instead, it was present at early years, probably related to initial widespread structural damage, and more likely to derive from a combination of complex factors including genetic susceptibility.
Authors/Disclosures
Mariana R. Brito, MD (Hospital De Clinicas Da Unicamp)
PRESENTER
No disclosure on file
No disclosure on file
Marina K. Alvim (Hospital Das Clinicas Unicamp) Dr. Alvim has nothing to disclose.
No disclosure on file
Clarissa L. Yasuda, MD, PhD (University of Campinas) Prof. Yasuda has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for LIBBS. Prof. Yasuda has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ABBOTT. Prof. Yasuda has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for LIBBS.
Marcia E. Morita-Sherman, MD (Eisai) An immediate family member of Dr. Morita-Sherman has received personal compensation for serving as an employee of Forrester Research. Dr. Morita-Sherman has received personal compensation for serving as an employee of Eisai Inc.. An immediate family member of Dr. Morita-Sherman has stock in Forrester Research. The institution of Dr. Morita-Sherman has received research support from Cleveland Clinic.
Fernando Cendes, MD, PhD, FAAN (Departamento de Neurologia; FCM; UNICAMP) Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharma. Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB Biopharma. Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for United Medical – Brazil. Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Zodiac Pharma . Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eurofarma – Brazil . Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Epilepsia. Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers in Neurology - Epilepsy. The institution of Dr. Cendes has received research support from São Paulo Research Foundation - FAPESP. The institution of Dr. Cendes has received research support from Conselho Nacional de Desenvolvimento Científico e Tecnológico - Brazil . The institution of Dr. Cendes has received research support from NIH.